technetium tc 99m sestamibi has been researched along with technetium tc-99m tetrofosmin in 175 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 67 (38.29) | 18.2507 |
| 2000's | 86 (49.14) | 29.6817 |
| 2010's | 19 (10.86) | 24.3611 |
| 2020's | 3 (1.71) | 2.80 |
| Authors | Studies |
|---|---|
| Bossuyt, A; Flamen, P; Franken, PR | 1 |
| Miller, DD | 1 |
| Katayama, M; Kosuda, S; Kusano, S; Yamamoto, O; Yokokawa, T; Yokoyama, H | 1 |
| Hayabuchi, N; Ishibashi, M; Kumabe, T; Matoba, F; Morita, S; Nishida, H; Nomura, G | 1 |
| Aigner, RM; Fueger, GF; Nicoletti, R | 1 |
| Gallowitsch, HJ; Lind, P | 1 |
| Middleton, GW; Williams, JH | 1 |
| Bakker, WH; Benjamins, H; Bernard, BF; Breeman, WA; de Jong, M; Ensing, G; Krenning, EP; Visser, TJ | 2 |
| Araki, T; Arbab, AS; Koizumi, K; Toyama, K | 1 |
| Ballinger, JR; Bannerman, J; Boxen, I; Firby, P; Hartman, NG; Moore, MJ | 1 |
| Del Vecchio, E; Mansi, L; Marino, G; Pecori, B; Rambaldi, PF | 1 |
| Daher, E; Jain, D; Makuch, R; Mattera, J; Naruse, H; Natale, D; Sinusas, A; Wackers, FJ | 1 |
| Leppo, JA; Marcel, R; Reinhardt, CP; Takahashi, N | 1 |
| Colao, A; Cuocolo, A; Klain, M; Lombardi, G; Marzano, L; Maurea, S; Salvatore, M | 1 |
| Benoit, T; Foulon, J; Rigo, P; Vivegnis, D | 1 |
| Gallowitsch, HJ; Gomez, I; Kresnik, E; Lind, P; Mikosch, P; Pipam, W | 1 |
| Hashimoto, J; Ishibashi, R; Kubo, A; Matsumoto, K; Nakamura, K; Sammiya, T | 1 |
| Gadsboll, N; Hesse, B; Widding, A | 1 |
| Matsunari, I; Münch, G; Neverve, J; Schröter, G; Schwaiger, M | 1 |
| Arai, T; Araki, T; Arbab, AS; Koizumi, K; Toyama, K | 2 |
| Lind, P | 2 |
| Aigner, RM; Fueger, GF; Wolf, G | 1 |
| Giordano, A; Meduri, G | 1 |
| Atahan, L; Bekdik, CF; Demirkazik, FB; Hayran, M; Kostakoglu, L; Ozyar, E; Uysal, U | 1 |
| Bauer, HC; Brosjö, O; Jacobsson, H; Jonsson, C; Söderlund, V | 1 |
| Clausen, OP; Erichsen, K; Fjeld, JG; Pfeffer, PF; Rootwelt, K | 1 |
| O'Doherty, MJ | 1 |
| Adams, SL; Hendel, RC; Kim, SC | 1 |
| Clarke, EA; Harding, LK; Notghi, A | 2 |
| Fellinger, J; Gallowitsch, HJ; Kresnik, E; Lind, P; Mikosch, P; Pipam, W; Unterweger, OF | 1 |
| Buscombe, JR; Cwikla, JB; Hilson, AJ; Thakrar, DS | 1 |
| Ajisaka, R; Hamada, M; Hashimoto, J; Kanbara, H; Konishi, J; Kudou, T; Kuwabara, Y; Masuda, Y; Murata, H; Nakajima, K; Nakano, T; Nishimura, T; Ohtake, T; Sakamoto, T; Sasaki, Y; Shimizu, H; Sugishita, Y; Tamaki, N | 1 |
| Fukunaga, M; Mimura, H; Morita, K; Otsuka, N; Sone, T; Tamada, T; Tomomitsu, T; Yanagimoto, S | 1 |
| Akçay, MN; Akin, Y; Karabağ, B; Oren, D; Ozcan, O | 1 |
| Ballinger, JR; Moore, MJ; Muzzammil, T | 2 |
| Burleigh, BD; Crankshaw, CL; Dahlheimer, J; Deutsch, KF; Luker, GD; Marmion, M; Piwnica-Worms, D; Rao, V; Webb, E | 1 |
| Hayabuchi, N; Hiromatsu, Y; Ishibashi, M; Kojima, K; Nishida, H; Tabuchi, E | 1 |
| Carnaille, B; Huglo, D; Oudar, C; Pattou, F; Proye, C; Racadot, A | 1 |
| Beller, GA; Caner, B | 1 |
| Fujii, T; Fujimoto, K; Hayabuchi, N; Ishibashi, M; Koganemaru, M; Ohzono, H | 1 |
| Cagnolini, A; Jurisson, S; Whitener, D | 1 |
| Cuocolo, A; Klain, M; Maurea, S; Salvatore, M | 1 |
| Everaert, H; Franken, PR; Hambye, AS; Maes, A; Mesotten, L; Mortelmans, L | 1 |
| Agren, BN; Göransson, MB; Jansson, BA | 1 |
| Lahiri, A; Raval, U; Smith, T | 1 |
| Bax, JJ; Cornel, JH; Elhendy, A; Geleijnse, ML; Krenning, EP; Nierop, PR; Reijs, AE; Roelandt, JR; Valkema, R; van Domburg, RT | 1 |
| Durántez, A; Ortiz Berrocal, J; Salas, C; Tabuenca, MJ; Varela, A; Vargas, JA | 1 |
| Champailler, A; Gremillet, E | 1 |
| Taillefer, R | 1 |
| Schneider, PB | 1 |
| Dendale, P; Everaert, H; Franken, PR; Schoors, D; Vanhove, C | 1 |
| Adalet, I; Alagöl, F; Cantez, S; Koçak, M; Ogŭz, H | 1 |
| Hayabuchi, N; Hiromatsu, Y; Ishibashi, M; Kohno, K; Nishida, H; Okuda, S; Uchida, M | 1 |
| Goris, ML; Hotz, B; Similon, P; Thirion, JP | 1 |
| Schneider, CM; Williams, KA | 1 |
| Aburano, T; Hiramatsu, T; Kinuya, S; Konishi, S; Michigishi, T; Shuke, N; Takayama, T; Tega, H; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
| Hoff, C; Kleinhans, E; Nowak, B; Reinartz, P; Sabri, O; Zimny, M | 1 |
| Cwajg, E; Cwajg, J; He, ZX; Hwang, WS; Keng, F; Nagueh, SF; Verani, MS | 1 |
| Kinuya, S; Matsunari, I; Miyazaki, Y; Muramori, A; Murata, Y; Nakajima, K; Taki, J; Tonami, N | 1 |
| Elgazzar, AH; Heiba, SI; Higazy, E; Saleh, M; Ziada, G | 1 |
| Fernãndez, A; Gonzalez, MT; Martin-Comin, J; Mora, J; Muñoz, A; Rafecas, R; Ramos, M; Vallejos, V | 1 |
| Carnaille, B; Huglo, D; Mondragon-Sanchez, A; N'Guyen, H; Pattou, F; Proye, C; Torres, G | 1 |
| Berger, A; Berghammer, P; Granegger, S; Hohlagschwandtner, M; Kubista, E; Kucera, H; Obwegeser, R; Rodrigues, M; Singer, C; Sinzinger, H | 1 |
| Nishimura, T | 1 |
| Bergmann, R; Brust, P; Johannsen, B; Pietzsch, HJ; Roux, F; Scheunemann, M; Seifert, S | 1 |
| Beauchesne, P; Dubois, F; Frere, D; Koumanov, F; Perek, N; Prevot, N; Sabido, O | 1 |
| Choi, JY; Kim, BT; Kim, JH; Kim, SE; Shin, HJ | 1 |
| Boersma, HH; De Muinck, E; Doevendans, PA; Dumont, EA; Heidendal, GA; Hofstra, L; Kemerink, GJ; Liem, IH; Reutelingsperger, CP; van Heerde, WL; Wellens, HJ | 1 |
| Berghammer, P; Chehne, F; Kalinowska, W; Rodrigues, M; Sinzinger, H; Zielinski, C | 1 |
| Aldershvile, J; Arendrup, H; Carlsen, J; Hesse, B; Mortensen, SA; Toft, JC | 1 |
| Arai, K; Goto, K; Goto, M; Harada, S; Hashimoto, T; Hishinuma, Y; Sugioka, Y; Yachuda, K | 1 |
| Eguchi, M; Hashimoto, A; Nakata, T; Shimamoto, K; Tsuchihashi, K | 1 |
| Hurwitz, GA; McLaughlin, DS; Slomka, PJ | 1 |
| Banzo, J; Dolores Abós, M; García López, F; Prats, E; Razola, P | 1 |
| Ballinger, JR; Ichise, M; Piquette-Miller, M; Rauth, AM; Su, ZF; Tang, W; Utsunomiya, K | 1 |
| Higashi, T; Imamura, M; Ishimori, T; Konishi, J; Mamede, M; Nakamoto, Y; Okazaki, K; Saga, T; Sakahara, H | 1 |
| Chehne, F; Kalinowska, W; Rodriques, M; Sinzinger, H; Zielinski, C | 1 |
| DePuey, EG; Lahiri, A; Soman, P; Taillefer, R; Udelson, JE | 1 |
| Chehne, F; Rodrigues, M; Sinzinger, H | 1 |
| Ballinger, JR | 1 |
| Bunko, H; Kinuya, S; Konishi, S; Li, XF; Ma, YY; Michigishi, T; Shuke, N; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
| Haas, F; Matsunari, I; Nguyen, NT; Reidel, G; Schwaiger, M; Senekowitsch-Schmidtke, R; Stöcklin, G; Wolf, I | 1 |
| Bai, J; Hashimoto, J; Iwanaga, S; Kubo, A; Mitamura, H; Nakahara, T; Ogawa, S; Suzuki, T | 1 |
| Kalinowska, W; Rodrigues, M; Sinzinger, H; Zielinski, C | 1 |
| Hutton, I; Keeble, W; Martin, W; McDade, M; Wright, GA | 1 |
| Hod, N; Horne, T; Strauss, S | 1 |
| Baumer, M; Cohen-Pour, M; Horne, T; Orda, R; Pappo, I | 1 |
| Casara, D; Giordano, A; Rubello, D | 1 |
| Antoniucci, D; Berni, G; Conti, A; Costanzo, E; Ferri, P; Francois, C; Gallini, C; Grifoni, S; Matteini, M; Migliorini, A; Paladini, B; Pieroni, C | 1 |
| Futami, S; Jinnouchi, S; Nagamachi, S; Noguchi, S; Tamura, S; Wakamatsu, H; Yamashita, H | 1 |
| Kim, IJ; Kim, SJ; Kim, YK | 2 |
| Brockmann, HA; Moka, D; Schaefer, WM; Schicha, H; Schomaecker, K | 1 |
| Borges-Neto, S; Coleman, RE; Hagge, RJ; Hanson, MW; Jain, D; Lima, HS; Pagnanelli, RA; Ravizzini, GC; Shaw, LK; Wong, TZ | 1 |
| Ishida, Y | 1 |
| Arrowood, JA; Jesse, RL; Kontos, MC; Kurdziel, K; McQueen, R; Nixon, JV; Ornato, JP; Paulsen, WH; Tatum, JL | 1 |
| Mari, C; Strauss, WH | 1 |
| Arsos, G; Karakatsanis, C; Karatzas, N; Koukoulidis, A; Venizelos, I | 1 |
| Buscombe, JR | 1 |
| Ding, HJ; Ho, ST; Kao, A; Shiau, YC; Tsai, SC; Wang, JJ | 1 |
| Boudard, D; Denoyer, D; Dubois, F; Koumanov, F; Perek, N | 1 |
| Kao, A; Lee, CC; Lin, CC; Sun, SS; Tsou, SS | 1 |
| Anagnostopoulos, C; Bomanji, J; Costa, DC; Davies, G; Dhawan, RT; Eastick, S; Ell, PJ; Jarritt, PH; Kapur, A; Latus, KA; Pennell, DJ; Prvulovich, EM; Roussakis, G; Underwood, SR; Young, MC | 1 |
| Araki, T; Arbab, AS; Koizumi, K; Ueki, J | 1 |
| Bonjer, HJ; Fröberg, AC; Krenning, EP; Valkema, R | 1 |
| Burroni, L; Cappagli, M; Giordano, A; Marozzi, P; Meduri, G; Rubini, G | 1 |
| Denoyer, D; Dubois, F; Koumanov, F; Perek, N | 1 |
| Fuster, D; Mallafré, C; Martín, F; Pavia, J; Pons, F; Viñolas, N | 1 |
| Matsunari, I | 1 |
| Bunko, H; Kinuya, S; Li, XF; Michigishi, T; Mori, H; Shiba, K; Shuke, N; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
| Britton, KE; Canizales, AL; Cholewa, M; Dziuk, MA; Pietrzykowski, J | 1 |
| Aktolun, C; Baum, RP; Bishof-Delaloye, A; Bombardieri, E; Buscombe, J; Chatal, JF; Maffioli, L; Moncayo, R; Mortelmans, L; Reske, SN | 1 |
| Madeddu, G; Spanu, A | 1 |
| Buscombe, JR; Schillaci, O | 1 |
| Fukumoto, M | 1 |
| Borges-Neto, S; Coleman, RE; Jain, D; Shaw, LK; Smith, WT; Tuttle, RH; Whellan, D | 1 |
| Denoyer, D; Dubois, F; Le Jeune, N; Perek, N | 2 |
| Beller, GA; Duatti, A; Glover, DK; Goode, AR; Hatada, K; Lima, RL; Riou, LM; Ruiz, M; Watson, DD; Yamamichi, Y | 1 |
| Lloyd, JJ; Peace, RA | 1 |
| Jesse, RL; Kontos, MC; Kurdziel, KA; Ornato, JP; Tatum, JL | 1 |
| Cengel, A; Turgut, B; Unlu, M | 1 |
| Madeddu, G; Schillaci, O; Spanu, A | 1 |
| Barrett, HH; Bettan, M; Furenlid, LR; Kastis, GA; Liu, Z; Stevenson, GD; Wilson, DW; Woolfenden, JM | 1 |
| Bellasi, A; Raggi, P; Ratti, C | 1 |
| Bateman, TM; Blackburn, B; Cerqueira, MD; Hendel, RC; Iskandrian, AE; Leppo, JA; Mahmarian, JJ | 1 |
| Bax, JJ; Dierckx, RA; Jager, PL; Slart, RH; van der Wall, EE; van Veldhuisen, DJ | 1 |
| Kawai, Y; Kishino, K | 1 |
| Davies, G; Edenbrandt, L; Götborg, CW; Latus, KA; Ohlsson, M; Richard Underwood, S; Tägil, K | 1 |
| Anagnostopoulos, C; Ell, PJ; Harbinson, M; Loong, CY; Prvulovich, E; Rahman, S; Reyes, E; Underwood, SR | 1 |
| Biersack, HJ; Bucerius, J; Guhlke, S; Joe, AY; Manka, C; Manka-Waluch, A; Palmedo, H; Reinhardt, MJ | 1 |
| Hara, M; Hirata, M; Hirose, K; Monzen, H; Nakanishi, A; Ogasawara, M; Sato, T; Shimoyama, H; Suzuki, T; Tadehara, F; Yuki, R | 1 |
| Delsarte, P; Hambÿe, AS; Vervaet, AM | 1 |
| Adams, GL; Borges-Neto, S; Hanson, MW; Pagnanelli, R; Shaw, LK; Tuttle, RH | 1 |
| Fukushima, K; Kasanuki, H; Kondo, C; Kusakabe, K; Momose, M | 1 |
| Friedman, NC; Loeb, HS | 1 |
| Brandão, C; Costa, MS; Domingues, FC; Duarte, PS; Oliveira, MA; Vieira, JG | 1 |
| Lwin, TT; Takeda, T; Wu, J | 1 |
| Alexiou, GA; Fotopoulos, AD; Kyritsis, AP; Polyzoidis, KS; Tsiouris, S; Voulgaris, S | 1 |
| Beju, D; Johnson, G; Liu, Z; Okada, DR; Okada, RD | 1 |
| Knollmann, D; Koch, KC; Krohn, T; Meyer, PT; Raptis, M; Schaefer, WM; Winz, OH | 1 |
| Bhatnagar, A; Chopra, MK; Jaimini, A; Kumar, N; Sawroop, K | 1 |
| Campistol, JM; Doménech, B; Fuster, D; Pons, F; Rubello, D; Setoain, X; Torregrosa, JV | 1 |
| Berman, DS; Cohen, I; Einstein, AJ; Friedman, JD; Hayes, SW; Kang, X; Kite, F; Nakazato, R; Slomka, PJ; Tamarappoo, B; Thomson, LE; Wolak, A | 1 |
| Bailey, D; Strauss, HW | 1 |
| Abrunhosa, AJ; Botelho, MF; Gomes, CM; Pauwels, EK | 1 |
| Ballinger, JR; Cheow, HK; Chilvers, ER; Hartman, NG; Peters, AM; Ruparelia, P; Shankar, S; Szczepura, KR | 1 |
| Altaner, S; Berkarda, S; Cukur, Z; Durmus-Altun, G; Ustun, F | 1 |
| Froberg, SA; Harris, AM; Hillel, PG; Taylor, JC; Tindale, WB | 1 |
| Askew, JW; Gibbons, RJ; Hodge, DO; Jordan, LG; Miller, TD; O'Connor, MK; Ruter, RL | 1 |
| Al-Saeedi, FJ; Bitar, M; Pariyani, S | 1 |
| Gomes, CM | 1 |
| Balogova, S; Cambal, M; Gregor, P; Kekenak, L; Kinova, S; Labas, P; Simkova, A; Stecova, A | 1 |
| D'Asseler, Y; Maes, A; Sathekge, M; Van de Wiele, C; Vorster, M | 1 |
| Chikamori, T; Hida, S; Igarashi, Y; Shiba, C; Takahashi, M; Tanaka, H; Tokuuye, K; Uchida, K; Yamashina, A; Yokoyama, T; Yoshimura, M | 1 |
| Danieli, R; Madeddu, G; Schillaci, O; Spanu, A | 1 |
| Higaki, J; Kawaguchi, N; Kido, T; Kurata, A; Miyagawa, M; Mochizuki, T; Nakamura, M; Nishiyama, Y; Ogimoto, A | 1 |
| Hogg, P; Szczepura, K; Tootell, AK | 1 |
| deKemp, RA; Klein, R; Lockwood, J; Marvin, B; Ruddy, TD; Timmins, R; Wei, L; Wells, RG | 1 |
| Aplin, M; de Belder, A; Dizdarevic, S; James, R; McCready, VR; Nair, S; Peters, AM; Ryan, N; Singh, N; Vara, A | 1 |
| Farrell, MB; Jerome, SD; Shaw, LJ; Tilkemeier, PL | 1 |
| Botushanov, NP; Botushanova, AD; Yaneva, MP | 1 |
| Camm, CF; Emery, A; Kelion, AD; Pavlitchouk, S; Rose-Innes, E; Sabharwal, N | 1 |
| Bateman, TM; Berman, DS; Betancur, J; Bokhari, S; Commandeur, F; Dey, D; Di Carli, M; Dorbala, S; Einstein, AJ; Fish, MB; Germano, G; Kaufmann, P; Miller, EJ; Motlagh, M; Otaki, Y; Ruddy, TD; Sharir, T; Sinusas, AJ; Slomka, PJ; Tamarappoo, BK | 1 |
| Chaudhuri, T; Fleming, MR; Fleming, RM; McKusick, A | 1 |
| Corbett, JR; Gupta, JI; Murthy, VL; Weinberg, RL | 1 |
| Duvall, WL; Henzlova, MJ | 1 |
| Doumas, A; Gerasimou, G; Papanastasiou, E; Siountas, A; Theodoridou, E | 1 |
| Case, J; Cerqueira, M; Duvall, WL; Lundbye, J | 1 |
| Corral, F; de la Fuente, C; Del Castillo, S; Fernandez-Vazquez, F; Garrote, C; Iglesias-Garriz, I; Lastra, JA; Rodríguez, E; Sevilla, A; Vara-Manso, J | 1 |
24 review(s) available for technetium tc 99m sestamibi and technetium tc-99m tetrofosmin
| Article | Year |
|---|---|
Role of nuclear cardiology in the evaluation of acute coronary syndromes.
Topics: Acute Disease; Algorithms; Coronary Disease; Cost-Benefit Analysis; Diagnosis, Differential; Echocardiography; Electrocardiography; Gated Blood-Pool Imaging; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Syndrome; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Triage | 1997 |
Scintigraphic imaging of breast cancer: a review.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Organophosphorus Compounds; Organotechnetium Compounds; Receptors, Estrogen; Receptors, Somatostatin; Reproducibility of Results; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed | 1997 |
Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
Topics: Animals; Coronary Disease; Electrocardiography; Humans; Myocardial Reperfusion; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis.
Topics: Breast Neoplasms; Female; Humans; Mammography; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
[Breast scintigraphy].
Topics: Adult; Artifacts; Axilla; Biopsy; Breast Diseases; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Resistance, Multiple; Drug Resistance, Neoplasm; False Positive Reactions; Female; Forecasting; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Organophosphorus Compounds; Organotechnetium Compounds; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Ultrasonography | 2001 |
[The use of imaging modalities in patient with thyroid nodule: ultrasonography and radionuclide scintigraphy with new tracers].
Topics: Diagnosis, Differential; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Ultrasonography | 2001 |
New trends in parathyroid scintigraphy.
Topics: Adenoma; Cost-Benefit Analysis; Humans; Hyperparathyroidism; Minimally Invasive Surgical Procedures; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Parathyroid Neoplasms; Radiopharmaceuticals; Subtraction Technique; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
[Significance of 99mTc-labeled perfusion agents in the simultaneous assessment of myocardial perfusion and cardiac function].
Topics: Coronary Circulation; Coronary Disease; Electrocardiography; Gated Blood-Pool Imaging; Humans; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Severity of Illness Index; Software; Systole; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2002 |
Detection and characterization of hibernating myocardium.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Heart; Heart Function Tests; Humans; Myocardial Stunning; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Low-grade chondrosarcomas: a difficult target for radionuclide imaging. Case report and review of the literature.
Topics: Aged; Bone Neoplasms; Chondrosarcoma; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes | 2002 |
Monitoring therapy in breast cancer.
Topics: Breast Neoplasms; Female; Humans; Monitoring, Physiologic; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Receptors, Estrogen; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Tetrofosmin as predictors of tumour response.
Topics: Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Multiple; Female; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Treatment Failure; Treatment Outcome | 2003 |
[Myocardial perfusion imaging].
Topics: Coronary Circulation; Heart; Humans; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed, Single-Photon | 2003 |
Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients.
Topics: Axilla; Breast Neoplasms; Cations; Humans; Lymph Nodes; Lymphatic Metastasis; Nuclear Medicine; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2004 |
Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin.
Topics: Animals; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Technology Assessment, Biomedical; Thallium; Tomography, Emission-Computed, Single-Photon | 2004 |
[99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.
Topics: Brain Neoplasms; Humans; Lung Neoplasms; Lymphoma; Medical Oncology; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Subtraction Technique; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2005 |
Ischemia imaging and plaque imaging in diabetes: complementary tools to improve cardiovascular risk management.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Echocardiography, Stress; Humans; Magnetic Resonance Angiography; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Radiography; Risk Management; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tunica Intima; Tunica Media | 2005 |
Imaging techniques in nuclear cardiology for the assessment of myocardial viability.
Topics: Coronary Disease; Fluorodeoxyglucose F18; Humans; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Rubidium Radioisotopes; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2006 |
99mTc-N-DBODC5: a novel myocardial perfusion imaging agent for diagnosis of coronary artery disease, a review.
Topics: Animals; Coronary Artery Disease; Coronary Circulation; Coronary Stenosis; Dogs; Heart; Humans; Liver; Organophosphorus Compounds; Organotechnetium Compounds; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2006 |
Localising imaging in secondary hyperparathyroidism.
Topics: Calcium; Diagnostic Imaging; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroidectomy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Iofetamine; Lung Neoplasms; Magnetic Resonance Imaging; Nuclear Medicine; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2012 |
Molecular breast imaging with gamma emitters.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Molecular Imaging; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2013 |
Nuclear Medicine Methods for Evaluation of Abnormal Parathyroid Glands in Patients with Primary and Secondary Hyperparathyroidism.
Topics: Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Nuclear Medicine; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2017 |
Efficiency of tetrofosmin versus sestamibi achieved through shorter injection-to-imaging times: A systematic review of the literature.
Topics: Heart Diseases; Humans; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon | 2021 |
20 trial(s) available for technetium tc 99m sestamibi and technetium tc-99m tetrofosmin
| Article | Year |
|---|---|
Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Topics: Aged; Coronary Disease; Dipyridamole; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; Organophosphorus Compounds; Organotechnetium Compounds; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1995 |
Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Topics: Coronary Disease; Exercise Test; Female; Half-Life; Heart; Humans; Liver; Male; Middle Aged; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1997 |
Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy.
Topics: Adenoma; Humans; Hyperparathyroidism; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1997 |
Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection.
Topics: Adult; Aged; Aged, 80 and over; Electrocardiography; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sex Characteristics; Stress, Physiological; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
Factors affecting and computation of myocardial perfusion reference images.
Topics: Adenosine; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Dipyridamole; Exercise Test; Female; Heart; Heart Diseases; Humans; Least-Squares Analysis; Male; Middle Aged; Models, Cardiovascular; Models, Statistical; Organophosphorus Compounds; Organotechnetium Compounds; Posture; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Regression Analysis; Sex Factors; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution | 1999 |
Can reduced imaging times be used for scintimammography?
Topics: Breast; Breast Neoplasms; Female; Humans; Lymph Node Excision; Mammography; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors | 1999 |
A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
Are ejection fractions from gated SPECT perfusion studies clinically useful? A comparison with radionuclide ventriculography.
Topics: Adult; Aged; Coronary Circulation; Female; Gated Blood-Pool Imaging; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Perfusion; Radionuclide Ventriculography; Radiopharmaceuticals; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
99Tc(m)-tetrofosmin scintimammography for detecting breast cancer: a comparative study with 99Tc(m)-MIBI.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2001 |
A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study.
Topics: Adenosine; Artifacts; Coronary Disease; Cross-Sectional Studies; Dobutamine; Exercise Test; Heart; Heart Diseases; Humans; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Quality Control; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium; United Kingdom | 2002 |
99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
Topics: Adenoma; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Parathyroid Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Technetium Tc 99m Sestamibi | 2003 |
The comparison of two gated SPET protocols: adenosine Tc-99m tetrofosmin and treadmill exercise Tc-99m MIBI.
Topics: Adenosine; Aged; Exercise Test; Female; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
The effect of imaging time, radiopharmaceutical, full fat milk and water on interfering extra-cardiac activity in myocardial perfusion single photon emission computed tomography.
Topics: Administration, Oral; Animals; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Milk; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon; Water | 2005 |
Dobutamine stress tetrofosmin SPECT; evaluation of short rest-stress protocol and head to head comparison with MIBI in detection of coronary artery disease.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Artery Disease; Dobutamine; Exercise Test; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Rest; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Electrocardiography; Heart; Humans; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Pilot Projects; Purines; Pyrazoles; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2005 |
Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi.
Topics: Aged; Coronary Artery Disease; Female; Humans; Male; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2007 |
Does P-glycoprotein have a role in the lung clearances of inhaled 99mTc-sestamibi and 99mTc-tetrofosmin?
Topics: Administration, Inhalation; Administration, Oral; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Female; Humans; Lung; Male; Metabolic Clearance Rate; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Smoking; Steroids; Technetium Tc 99m Sestamibi | 2009 |
Comparison of myocardial perfusion imaging between the new high-speed gamma camera and the standard anger camera.
Topics: Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2013 |
Combined supine and prone myocardial perfusion single-photon emission computed tomography with a cadmium zinc telluride camera for detection of coronary artery disease.
Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Humans; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2014 |
Early gated SPECT adenosine myocardial perfusion imaging may influence the therapeutic management of patients with coronary artery disease.
Topics: Adenosine; Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Stroke Volume; Technetium Tc 99m Sestamibi; Time Factors; Ventricular Dysfunction, Left | 2015 |
131 other study(ies) available for technetium tc 99m sestamibi and technetium tc-99m tetrofosmin
| Article | Year |
|---|---|
The growing flood of technetium-99m myocardial perfusion agents. More water ... or more mud?
Topics: Heart; Humans; Myocardial Reperfusion; Organophosphorus Compounds; Organotechnetium Compounds; Oximes; Radionuclide Imaging; Technetium; Technetium Tc 99m Sestamibi | 1995 |
Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Bone Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyroid Neoplasms | 1995 |
Tc-99m tetrofosmin. A new diagnostic tracer for parathyroid imaging.
Topics: Adenoma; Adult; Female; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Neoplasms; Radionuclide Imaging; Subtraction Technique; Technetium Tc 99m Sestamibi | 1995 |
Parathyroid scintigraphy: comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies.
Topics: Adenoma; Aged; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Neoplasms; Prospective Studies; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1996 |
The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Whole-Body Counting | 1996 |
Interference from duodeno-gastric reflux of 99Tcm radiopharmaceuticals in SPET myocardial perfusion imaging.
Topics: Duodenogastric Reflux; Heart; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Posture; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Furans; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Time Factors; Tumor Cells, Cultured | 1996 |
Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Enzyme Inhibitors; Humans; Ionophores; Nigericin; Organophosphorus Compounds; Organotechnetium Compounds; Ouabain; Sodium-Potassium-Exchanging ATPase; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tumor Cells, Cultured; Uncoupling Agents | 1996 |
Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mammary Neoplasms, Experimental; Organophosphorus Compounds; Organotechnetium Compounds; Rats; Technetium Tc 99m Sestamibi; Time Factors; Tumor Cells, Cultured | 1996 |
Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
Topics: Adenoma; Aged; Female; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Parathyroid Neoplasms; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Subtraction Technique; Technetium Tc 99m Sestamibi; Thyroid Gland | 1996 |
Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin.
Topics: Adult; Exercise Test; Female; Furans; Heart; Humans; Image Processing, Computer-Assisted; Male; Organophosphorus Compounds; Organotechnetium Compounds; Reference Values; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1996 |
Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201Tl in a model of acute coronary reperfusion.
Topics: Animals; Coronary Circulation; Coronary Disease; Hemodynamics; Male; Myocardial Reperfusion; Myocardium; Nitroblue Tetrazolium; Organophosphorus Compounds; Organotechnetium Compounds; Rats; Rats, Sprague-Dawley; Staining and Labeling; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes | 1996 |
Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
Topics: Adenoma; Female; Goiter, Nodular; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Thyroid Nodule | 1996 |
Quantitative evaluation of myocardial single-photon emission tomographic imaging: application to the measurement of perfusion defect size and severity.
Topics: Coronary Disease; Exercise Test; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Phantoms, Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
Topics: Aged; Aged, 80 and over; Analysis of Variance; False Negative Reactions; False Positive Reactions; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Organophosphorus Compounds; Organotechnetium Compounds; Radioimmunoassay; Radionuclide Imaging; Recurrence; Reproducibility of Results; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroglobulin; Thyroid Neoplasms; Time Factors | 1996 |
Comparison of cationic myocardial perfusion agents: characteristics of accumulation in cultured smooth muscle cells.
Topics: Antimetabolites; Biological Transport, Active; Cells, Cultured; Heart; Humans; Muscle, Smooth, Vascular; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes | 1996 |
Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: can we use the same reference data base?
Topics: Coronary Disease; Dipyridamole; Exercise Test; Female; Heart; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reference Values; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1997 |
Ion transport systems in the uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201Tl in a tumour cell line.
Topics: Amiloride; Biological Transport; Bumetanide; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carrier Proteins; Contrast Media; Humans; Kinetics; Organophosphorus Compounds; Organotechnetium Compounds; Ouabain; Potassium; Sodium; Sodium-Hydrogen Exchangers; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tumor Cells, Cultured | 1997 |
Parathyroid imaging with technetium-99m labelled cationic complexes: which tracer and which technique should be used?
Topics: Adenoma; Humans; Hyperparathyroidism; Methods; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Neoplasms; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon | 1997 |
Parathyroid scintigraphy: first experiences with technetium (III)-99m-Q12.
Topics: Adenoma; Adult; Aged; Feasibility Studies; Female; Furans; Humans; Hyperparathyroidism; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Neoplasms; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma.
Topics: Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Humans; Male; Middle Aged; Muscle Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Technetium Tc 99m Sestamibi | 1997 |
Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Topics: Adenoma; Aged; Female; Humans; Hyperparathyroidism; Male; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi; Thyroid Gland; Time Factors | 1997 |
Radionuclide parathyroid imaging.
Topics: Adenoma; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Are MIBI/tetrofosmin heart studies a potential radiation hazard to technologists?
Topics: Adenosine; Adrenergic beta-Agonists; Allied Health Personnel; Dobutamine; Exercise Test; Female; Heart; Humans; Nuclear Medicine; Occupational Exposure; Organophosphorus Compounds; Organotechnetium Compounds; Pregnancy; Radiation Dosage; Radionuclide Imaging; Radiopharmaceuticals; Stress, Physiological; Technetium Tc 99m Sestamibi | 1997 |
[Use of a gamma probe for intraoperative localization of parathyroid adenomas with Tc-99m-tetrofosmin and Tc-99m-sestamibi].
Topics: Adenoma; Adult; Aged; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Parathyroid Neoplasms; Parathyroidectomy; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
[Typical normal cases and normal cases with abnormal image pattern in every myocardial SPECT radiopharmaceutical].
Topics: 3-Iodobenzylguanidine; Fatty Acids; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1997 |
[Comparative study on the tumor accumulation of 99mTc-tetrofosmin and 99mTc-MIBI in rabbits bearing VX-2 cancer].
Topics: Animals; Neoplasm Transplantation; Neoplasms, Experimental; Organophosphorus Compounds; Organotechnetium Compounds; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1997 |
Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Drug Resistance, Neoplasm; Female; Furans; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 1997 |
Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Neoplasm; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 1998 |
Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.
Topics: Amiloride; Animals; Bumetanide; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Survival; Cells, Cultured; Heart; Ion Transport; Membrane Potentials; Mitochondria, Heart; Monensin; Myocardium; Nigericin; Organophosphorus Compounds; Organotechnetium Compounds; Ouabain; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sodium; Technetium Tc 99m Sestamibi; Tetrodotoxin; Thallium Radioisotopes | 1998 |
Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Topics: Adenoma; Adult; Aged; Female; Humans; Hyperparathyroidism; Hyperplasia; Magnetic Resonance Imaging; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography | 1998 |
Localization of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or tetrofosmine.
Topics: Female; Humans; Hyperparathyroidism; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Sestamibi; Veins | 1998 |
99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Membrane; Female; Furans; Humans; Kinetics; Male; Mitochondria; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Rats, Wistar; Technetium Tc 99m Sestamibi; Tissue Distribution; Tumor Cells, Cultured | 1998 |
Discordant washout of 99mTc sestamibi and 99mTc tetrofosmin in a patient with mediastinal seminoma.
Topics: Adult; Humans; Male; Mediastinal Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Seminoma; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
Comparison of the kit performance of three 99mTc myocardial perfusion agents.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Heart; Organophosphorus Compounds; Organotechnetium Compounds; Perfusion; Quality Control; Radionuclide Imaging; Radiopharmaceuticals; Reagent Kits, Diagnostic; Technetium Tc 99m Sestamibi | 1998 |
Tetrofosmin thyroid scintigraphy.
Topics: Antineoplastic Agents; Breast Neoplasms; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thyroid Gland; Tomography, Emission-Computed, Single-Photon | 1998 |
Nuclear cardiology, Part III: Scintigraphic evaluation of cardiac perfusion.
Topics: Coronary Circulation; Coronary Disease; Coronary Vessels; Electrocardiography; Exercise Test; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventriculography, First-Pass | 1998 |
Adsorption of some technetium-99m radiopharmaceuticals onto disposable plastic syringes.
Topics: Adsorption; Disposable Equipment; Furans; Lysine; Materials Testing; Organophosphorus Compounds; Organotechnetium Compounds; Plastics; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Sulfhydryl Compounds; Surface Properties; Syringes; Technetium Compounds; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Time Factors | 1998 |
Influence of background correction in the estimation of myocardial uptake of 99mTc labelled perfusion imaging agents.
Topics: Adult; Aged; Exercise Test; Female; Heart; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Phantoms, Imaging; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1998 |
Safety of dobutamine-atropine stress myocardial perfusion scintigraphy.
Topics: Atropine; Coronary Disease; Dobutamine; Feasibility Studies; Female; Heart; Humans; Hypotension; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Risk Factors; Safety; Tachycardia; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1998 |
Technetium-99m-tetrofosmin scintigraphy, P-glycoprotein and lung cancer.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Humans; Lung Diseases; Lung Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
Parathyroid scanning accuracies.
Topics: Humans; Magnetic Resonance Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Diseases; Parathyroid Glands; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
Quantitative assessment of regional dysfunction from gated single photon emission tomography myocardial perfusion studies: a non-segmental approach.
Topics: Adult; Aged; Case-Control Studies; Female; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Myocardial Infarction; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1999 |
Determination of medullary thyroid carcinoma metastases by 201Tl, 99Tcm(V)DMSA, 99Tcm-MIBI and 99Tcm-tetrofosmin.
Topics: Adult; Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms | 1999 |
Pre-surgical localization of ectopic parathyroid glands using three-dimensional CT imaging, 99Tcm sestamibi, and 99Tcm tetrofosmin imaging.
Topics: Choristoma; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 1999 |
Multi-tracer imaging of thyroid nodules: is there a role in the preoperative assessment of nodular goiter?
Topics: Goiter, Nodular; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Thyroid Nodule; Tomography, Emission-Computed | 1999 |
Increased stress right ventricular activity on dual isotope perfusion SPECT: a sign of multivessel and/or left main coronary artery disease.
Topics: Coronary Circulation; Coronary Disease; Exercise Test; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left; Ventricular Function, Right | 1999 |
Early response of tumour to radiotherapy should be assessed by both uptake and retention of single photon tracers: in vitro analysis with 201Tl-chloride, 99Tcm-sestamibi and 99Tcm-tetrofosmin in human bladder cancer cells and human leukocytes.
Topics: Humans; In Vitro Techniques; Leukocytes; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1999 |
[Various dynamics of Tc-99m-tetrofosmin and Tc-99m-MIBI in a parathyroid adenoma].
Topics: Adenoma; Female; Humans; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed; Ultrasonography | 1999 |
Gated myocardial perfusion tomography for the assessment of left ventricular function and volumes: comparison with echocardiography.
Topics: Echocardiography; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Stroke Volume; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 1999 |
Forward cardiac output measurement with first-pass technique using 99mTc-labeled myocardial perfusion imaging agents.
Topics: Aged; Cardiac Output; Erythrocytes; Female; Humans; Male; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventriculography, First-Pass | 1999 |
Assessment of 99Tcm-tetrofosmin lung uptake: a modified method to avoid the contribution from high chest wall activity.
Topics: Adult; Biological Transport; Blood Pressure; Exercise Test; Heart; Heart Rate; Hemodynamics; Humans; Lung; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reference Values; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 1998 |
The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Topics: Adenoma; Adult; Aged; Evaluation Studies as Topic; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Sodium Pertechnetate Tc 99m; Subtraction Technique; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Gland; Time Factors | 1999 |
Correlation of parathyroid scanning and anatomy in 261 unselected patients with sporadic primary hyperparathyroidism.
Topics: Adult; Aged; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Organ Size; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
[Progress in nuclear diagnosis].
Topics: Fatty Acids; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Genes, MDR; Humans; Immunoblotting; Organophosphorus Compounds; Organotechnetium Compounds; Phenotype; Radiopharmaceuticals; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2000 |
Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines.
Topics: Antibodies, Monoclonal; ATP-Binding Cassette Transporters; Biomarkers, Tumor; Brain Neoplasms; Flow Cytometry; Genes, MDR; Glioma; Glutathione; Humans; Immunoglobulin G; Multidrug Resistance-Associated Proteins; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2000 |
Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Visualisation of cell death in vivo in patients with acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Annexin A5; Apoptosis; Cell Death; Coronary Circulation; Coronary Vessels; Female; Follow-Up Studies; Heart; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Protein Binding; Radiopharmaceuticals; Reperfusion Injury; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2000 |
Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines.
Topics: Adenocarcinoma; Biological Transport; Breast; Breast Neoplasms; Cell Line; Female; Humans; Kinetics; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2000 |
Myocardial perfusion scintigraphy as a screening method for significant coronary artery stenosis in cardiac transplant recipients.
Topics: Adolescent; Adult; Child; Coronary Angiography; Coronary Disease; Female; Heart; Heart Transplantation; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2000 |
Uptake of 99mTc-tetrofosmin, 99mTc-MIBI and 201Tl in malignant thymoma.
Topics: Aged; Bone Neoplasms; Humans; Male; Organophosphorus Compounds; Organotechnetium Compounds; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thymoma; Thymus Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2000 |
In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors.
Topics: Acridines; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Drug Resistance, Neoplasm; Furans; Humans; Isoquinolines; Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Technetium Tc 99m Sestamibi; Tetrahydroisoquinolines; Tomography, Emission-Computed, Single-Photon; Tumor Cells, Cultured | 2000 |
Right ventricular abnormalities assessed by myocardial single-photon emission computed tomography using technetium-99m sestamibi/tetrofosmin in right ventricle-originated ventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Cardiomyopathies; Child; Female; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Ventriculography; Radiopharmaceuticals; Sensitivity and Specificity; Tachycardia, Ventricular; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2000 |
Comparing the image quality of myocardial perfusion agents in the clinical laboratory: small test groups and large reference populations.
Topics: Exercise Test; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2000 |
Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Genes, MDR; Humans; Indicators and Reagents; Nasopharyngeal Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2000 |
FDG-PET of autoimmune-related pancreatitis: preliminary results.
Topics: Cell Survival; Chondrosarcoma; Fibrosarcoma; Furans; Humans; Liposarcoma; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sarcoma; Sarcoma, Synovial; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2000 |
Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.
Topics: Cell Survival; Chondrosarcoma; Fibrosarcoma; Humans; Liposarcoma; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sarcoma; Sarcoma, Synovial; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2000 |
Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.
Topics: Adult; Aged; Coronary Circulation; Coronary Disease; Dipyridamole; Exercise Test; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2001 |
In vitro adsorption of 99Tc(m)-MIBI, 99Tc(m)-tetrofosmin, 99Tc(m)-furifosmin and 99Tc(m)O4- onto tubes.
Topics: Adsorption; Furans; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2001 |
Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Substrate Specificity; Technetium Tc 99m Sestamibi | 2001 |
Technetium-99m-tetrofosmin would be a substrate for multidrug resistance-associated protein (MRP): comparison between a leukemia cell line with high MRP gene expression and its parental cell line.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Calcium Channel Blockers; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Kinetics; Neoplasm Proteins; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Substrate Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Verapamil | 2001 |
Comparison of sestamibi, tetrofosmin, and Q12 retention in porcine myocardium.
Topics: Animals; Blood Pressure; Coronary Circulation; Dipyridamole; Dobutamine; Furans; Heart; Heart Rate; Linear Models; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Swine; Technetium Tc 99m Sestamibi | 2001 |
Comparison of image reconstruction algorithms in myocardial perfusion scintigraphy.
Topics: Algorithms; Chi-Square Distribution; Coronary Angiography; Coronary Disease; Dipyridamole; Exercise Test; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Rest; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Calcium Channel Blockers; Cell Line; Cell Survival; Female; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured; Verapamil | 2001 |
Early detection of myocardial ischaemia in the emergency department by rest or exercise (99m)Tc tracer myocardial SPET in patients with chest pain and non-diagnostic ECG.
Topics: Aged; Chest Pain; Electrocardiography; Emergency Service, Hospital; Exercise Test; Female; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
Topics: Adult; Aged; Case-Control Studies; Female; Humans; Hyperparathyroidism; Magnetic Resonance Imaging; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Sestamibi; Thallium Radioisotopes | 2001 |
Tc-99m MIBI, Tc-99m tetrofosmin, and Tc-99m (V) DMSA accumulation in recurrent malignant thymoma.
Topics: Aged; Female; Humans; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi; Thymoma; Thymus Neoplasms | 2002 |
201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts.
Topics: Animals; Furans; Guinea Pigs; In Vitro Techniques; Male; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors | 2002 |
Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies.
Topics: Adenosine; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon | 2002 |
Comparison of 2-dimensional echocardiography and myocardial perfusion imaging for diagnosing myocardial infarction in emergency department patients.
Topics: Biomarkers; Cardiology Service, Hospital; Clinical Enzyme Tests; Creatine Kinase; Echocardiography; Emergency Service, Hospital; False Negative Reactions; Female; Humans; Male; Middle Aged; Myocardial Infarction; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2002 |
Uptake of 99mTc tetrofosmin in lymphoma cell lines: a comparative study with 99mTc sestamibi.
Topics: Biological Transport; Hodgkin Disease; Humans; Kinetics; Lymphoma; Lymphoma, B-Cell; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2002 |
Modulation of the multidrug resistance of glioma by glutathione levels depletion--interaction with Tc-99M-Sestamibi and Tc-99M-Tetrofosmin.
Topics: Annexin A5; Antimetabolites; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Buthionine Sulfoximine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioma; Glutathione; Humans; Membrane Potentials; Mitochondria; Multidrug Resistance-Associated Proteins; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2002 |
Exercise and rest technetium-99m-tetrofosmin lung uptake: correlation with left ventricular ejection fraction in patients with coronary artery disease.
Topics: Adult; Aged; Coronary Disease; Exercise; Exercise Test; Female; Humans; Lung; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Rest; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventriculography, First-Pass | 2002 |
Effects of extracellular Na+ and Ca2+ ions and Ca2+ channel modulators on the cell-associated activity of 99mTc-MIBI and 99mTc-tetrofosmin in tumour cells.
Topics: Amiloride; Animals; Antineoplastic Agents; Calcium; Calcium Channels; Carcinoma, Lewis Lung; Cell Survival; Extracellular Space; Flunarizine; Glioma; Humans; Ion Channel Gating; Metabolic Clearance Rate; Mice; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sodium; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured; Verapamil | 2003 |
Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
Topics: Biological Transport; Humans; Hyperparathyroidism; Italy; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Salivary Glands; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi; Thyroid Gland; Tissue Distribution | 2003 |
Malignant gliomas display altered plasma membrane potential and pH regulation--interaction with Tc-99m-MIBI and Tc-99m-Tetrofosmin uptakes.
Topics: Glioma; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Multidrug Resistance-Associated Proteins; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sodium-Hydrogen Exchangers; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2002 |
Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Humans; Metabolic Clearance Rate; Multidrug Resistance-Associated Proteins; Organophosphorus Compounds; Organotechnetium Compounds; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2003 |
Breast scintigraphy: procedure guidelines for tumour imaging.
Topics: Breast; Breast Neoplasms; Europe; Humans; Nuclear Medicine; Organophosphorus Compounds; Organotechnetium Compounds; Patient Care Management; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Societies, Medical; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2003 |
Breast scintigraphy today: indications and limitations.
Topics: Breast Neoplasms; Clinical Trials as Topic; Humans; Lymphatic Metastasis; Organophosphorus Compounds; Organotechnetium Compounds; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Technetium Tc 99m Sestamibi; Technology Assessment, Biomedical; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2004 |
Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
Topics: Adenosine; Aged; Cardiovascular Diseases; Coronary Circulation; Coronary Disease; Dipyridamole; Dobutamine; Exercise Test; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Proportional Hazards Models; Risk Assessment; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2004 |
Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99m-sestamibi and Tc-99m-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cells.
Topics: Biological Transport; Buthionine Sulfoximine; Cell Line, Tumor; Cholesterol Esters; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioma; Glutathione; Humans; Membrane Lipids; Multidrug Resistance-Associated Proteins; Organophosphorus Compounds; Organotechnetium Compounds; Technetium Tc 99m Sestamibi | 2004 |
99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Topics: Animals; Heart; Liver; Lung; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Technetium Tc 99m Sestamibi | 2004 |
Myocardial salvage in patients with non-ST-elevation myocardial infarction determined by myocardial perfusion imaging.
Topics: Female; Humans; Male; Middle Aged; Myocardial Infarction; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells.
Topics: Catalysis; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioma; Glutathione; Humans; Kinetics; Multidrug Resistance-Associated Proteins; Organophosphorus Compounds; Organotechnetium Compounds; Phenotype; Technetium Tc 99m Sestamibi | 2005 |
Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Topics: Adenocarcinoma; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Breast Neoplasms; Cyclosporins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |
[Safety of adenosine stress myocardial perfusion imaging by a one-route infusion protocol].
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Angina Pectoris; Blood Pressure; Coronary Artery Disease; Heart; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2006 |
Patient gender and radiopharmaceutical tracer is of minor importance for the interpretation of myocardial perfusion images using an artificial neural network.
Topics: Adult; Aged; Aged, 80 and over; Female; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neural Networks, Computer; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sex Factors; Technetium Tc 99m Sestamibi; Thallium Radioisotopes | 2006 |
A comparison of Tl-201, Tc-99m sestamibi, and Tc-99m tetrofosmin myocardial perfusion scintigraphy in patients with mild to moderate coronary stenosis.
Topics: Coronary Stenosis; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; Technetium Tc 99m Sestamibi; Thallium | 2006 |
Myocardial uptake characteristics of three 99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection.
Topics: Coronary Artery Disease; Female; Heart; Humans; Injections, Intra-Arterial; Lung; Male; Metabolic Clearance Rate; Middle Aged; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Rest; Technetium Tc 99m Sestamibi; Tissue Distribution; Ventricular Dysfunction, Left; Whole Body Imaging | 2006 |
Exploring a technique for reducing the influence of scattered rays from surrounding organs to the heart during myocardial perfusion scintigraphy with technetium-99m sestamibi and technetium-99m tetrofosmin.
Topics: Aged; Artifacts; Female; Heart; Humans; Image Enhancement; Male; Organophosphorus Compounds; Organotechnetium Compounds; Perfusion; Phantoms, Imaging; Posture; Radiopharmaceuticals; Reproducibility of Results; Scattering, Radiation; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2006 |
Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice.
Topics: Artifacts; Digestion; Exercise Test; Female; Humans; Kinetics; Liver; Male; Metabolic Clearance Rate; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Perfusion; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Rest; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 2007 |
Myocardial kinetics of (201)Thallium, (99m)Tc-tetrofosmin, and (99m)Tc-sestamibi in an acute ischemia-reperfusion model using isolated rat heart.
Topics: Animals; Equipment Design; Heart; Kinetics; Male; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Perfusion; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reperfusion Injury; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Time Factors | 2007 |
Normalization of abnormal T-waves during stress testing does not identify patients with reversible perfusion defects.
Topics: Aged; Atropine; Blood Pressure; Cardiotonic Agents; Case-Control Studies; Dobutamine; Electrocardiography; Exercise Test; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Regression Analysis; Research Design; Retrospective Studies; Sensitivity and Specificity; Stress, Physiological; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2007 |
Discordant results in Tc-99m tetrofosmin and Tc-99m sestamibi parathyroid scintigraphies.
Topics: Aged; Female; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2007 |
On M. Krengli, G. Loi, G. Sacchetti et al. Delineation of Target Volume for Radiotherapy of High-Grade Gliomas by (99)mTc-MIBI SPECT and MRI Fusion in: Strahlenther Onkol 2007;183:689-94 (No. 12).
Topics: Brain Neoplasms; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2008 |
Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
Topics: Animals; Creatine Kinase; Furans; Heart; In Vitro Techniques; Kinetics; Male; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Technetium Tc 99m Sestamibi; Tetrazolium Salts | 2008 |
Gated myocardial perfusion SPECT: algorithm-specific influence of reorientation on calculation of left ventricular volumes and ejection fraction.
Topics: Adult; Aged; Algorithms; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Perfusion; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2008 |
Ventilation scintigraphy with lipophilic cationic compounds.
Topics: Adult; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Organophosphorus Compounds; Organotechnetium Compounds; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pulmonary Ventilation; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Pentetate; Technetium Tc 99m Sestamibi | 2008 |
Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: Visual and quantitative analyses.
Topics: Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi | 2008 |
Stress thallium-201/rest technetium-99m sequential dual isotope high-speed myocardial perfusion imaging.
Topics: Adenosine; Aged; Exercise Test; Female; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiation Dosage; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon | 2009 |
Resurrection of thallium-201 for myocardial perfusion imaging.
Topics: Adenosine; Exercise Test; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiation Dosage; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon | 2009 |
P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line, Tumor; Cyclosporins; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Small Cell Lung Carcinoma; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured; Verapamil | 2009 |
Glucose-induced alteration of accumulation of organotechnetium complexes accumulation in Pgp-negative tumor-bearing mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Glucose; Carcinoma, Ehrlich Tumor; Data Interpretation, Statistical; Female; Glucose; Metabolism; Mice; Mice, Inbred BALB C; Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2009 |
Correlation of left ventricular count rate with patient weight in Tc-99m myocardial perfusion imaging.
Topics: Body Weight; Female; Humans; Male; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reference Values; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2011 |
Early image acquisition using a solid-state cardiac camera for fast myocardial perfusion imaging.
Topics: Aged; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Technetium Tc 99m Sestamibi; Time Factors | 2011 |
Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells.
Topics: Anti-Infective Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Metabolic Clearance Rate; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Triterpenes | 2011 |
Cationic lipophilic radiotracers for functional imaging of multidrug resistance.
Topics: Animals; ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mice; Multidrug Resistance-Associated Proteins; Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; ROC Curve; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2012 |
From preoperative to intraoperative detection of hyperfunctioning parathyroid glands using tetrofosmin (99mTc) in primary hyperparathyroidism.
Topics: Humans; Hyperparathyroidism, Primary; Intraoperative Period; Minimally Invasive Surgical Procedures; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands; Parathyroid Neoplasms; Parathyroidectomy; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2011 |
Comparison of effective dose and lifetime risk of cancer incidence of CT attenuation correction acquisitions and radiopharmaceutical administration for myocardial perfusion imaging.
Topics: Female; Humans; Incidence; Male; Middle Aged; Myocardial Perfusion Imaging; Neoplasms; Netherlands; Organophosphorus Compounds; Organotechnetium Compounds; Radiometry; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thermoluminescent Dosimetry; Tomography, X-Ray Computed | 2014 |
Dynamic SPECT measurement of absolute myocardial blood flow in a porcine model.
Topics: Animals; Blood Flow Velocity; Coronary Occlusion; Coronary Vessels; Disease Models, Animal; Humans; Image Processing, Computer-Assisted; Kinetics; Models, Statistical; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Swine; Technetium Tc 99m Sestamibi; Thallium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Nationwide Laboratory Adherence to Myocardial Perfusion Imaging Radiation Dose Reduction Practices: A Report From the Intersocietal Accreditation Commission Data Repository.
Topics: Accreditation; Clinical Laboratory Techniques; Computer Simulation; Coronary Circulation; Databases, Factual; Guideline Adherence; Heart Diseases; Humans; Laboratory Proficiency Testing; Myocardial Perfusion Imaging; Observer Variation; Organophosphorus Compounds; Organotechnetium Compounds; Practice Guidelines as Topic; Predictive Value of Tests; Radiation Dosage; Radiation Exposure; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi; United States | 2015 |
How variable are the volumetric measurements from gated perfusion SPECT when a one-day stress-rest protocol is used?
Topics: Aged; Confidence Intervals; Coronary Artery Disease; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Reproducibility of Results; Retrospective Studies; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2019 |
Deep Learning for Prediction of Obstructive Disease From Fast Myocardial Perfusion SPECT: A Multicenter Study.
Topics: Aged; Aged, 80 and over; Coronary Circulation; Coronary Stenosis; Deep Learning; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Registries; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2018 |
FMTVDM-TFM
Topics: Calibration; Coronary Artery Disease; Heart; Humans; Molecular Imaging; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2019 |
What is this image? 2019: Image 5 result : Gastroesophageal reflux: An unexpected cause of chest pain identified by review of planar images and coregistered SPECT-CT images.
Topics: Aged; Cardiology; Chest Pain; Diabetes Mellitus, Type 2; Esophageal Neoplasms; Esophagectomy; Gastroesophageal Reflux; Humans; Hyperlipidemias; Hypertension; Male; Microcirculation; Organophosphorus Compounds; Organotechnetium Compounds; Risk Factors; Single Photon Emission Computed Tomography Computed Tomography; Stroke; Technetium Tc 99m Sestamibi | 2019 |
Did we solve soft tissue (breast) attenuation?
Topics: Artifacts; Breast; Breast Neoplasms; Coronary Artery Disease; False Positive Reactions; Female; Humans; Image Processing, Computer-Assisted; Male; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Phantoms, Imaging; Prognosis; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2021 |
A study on the optimization of the administered activity in myocardial perfusion SPECT imaging with Tc-99m according to body measurements.
Topics: Body Mass Index; Body Weight; Female; Humans; Male; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2019 |
Diagnostic accuracy of regadenoson stress echocardiography: concordance with gated-spect myocardial perfusion imaging.
Topics: Aged; Cardiac-Gated Imaging Techniques; Comorbidity; Echocardiography, Stress; Female; Heart Disease Risk Factors; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Prevalence; Purines; Pyrazoles; Radiopharmaceuticals; Reproducibility of Results; Smoking; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2021 |